Evidence map›Paper›PMID 28361459›Full record

ArticleFolia microbiologica2017

Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.

Vladimír Hrabovský, Victoria Takáčová, Eva Schréterová, Lydia Pastvová, Zuzana Hrabovská, Katarina Čurová, Leonard Siegfried

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Hydralazine potentiates the antiproliferative effect of photodynamic therapy on Candida albicans and Candida parapsilosis in vitro.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vladimír HrabovskýInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia. vladimir.hrabovsky@upjs.sk.
Victoria TakáčováInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
Eva SchréterováInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
Lydia PastvováInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
Zuzana HrabovskáDepartment of Dermatovenerology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
Katarina ČurováInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
Leonard SiegfriedInstitute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.

Funding

European Regional Development Fund Verzdrav ITMS: 262220220197
6 · The paper itself

Abstract

Yeasts frequently colonize non-sterile sites in the body. The aim of the study was to determine distribution in clinical samples and antifungal susceptibility to five antifungals. From January 2013 through June 2015, 800 isolates were obtained from intensive care unit patients. Candida albicans (58.9%), Candida glabrata (20.4%), Candida krusei (8.6%), and Candida parapsilosis (3.6%) were the leading species. Majority of the C. albicans isolates were susceptible to the fluconazole. Elevated voriconazole minimal inhibitory concentrations (MICs) were observed in isolates exhibiting high fluconazole MICs, most frequently in C. glabrata. Isolates with echinocandins MICs suggesting reduced susceptibility were only sporadic cases with the exception of Trichosporon spp. The amphotericin B MICs were slightly higher for some C. krusei.

Indexed as

Amphotericin BAntifungal AgentsCandidaCandidiasisDrug Resistance, FungalFluconazoleHumansIntensive Care UnitsMicrobial Sensitivity TestsVoriconazoleAmphotericin BAntifungal AgentsFluconazoleVoriconazoleAntifungal DrugCaspofunginInvasive Fungal InfectionTriazoleVoriconazole

Identifiers

PMID28361459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.